- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
10 result(s) found for: Lyme Disease.
Displaying page 1 of 1.
EudraCT Number: 2009-010939-40 | Sponsor Protocol Number: PLEASE | Start Date*: 2010-04-29 | |||||||||||||||||||||||||||||||
Sponsor Name:UMCN St Radboud | |||||||||||||||||||||||||||||||||
Full Title: PLEASE Persistent Lyme Empiric Antibiotic Study Europe. A prospective, randomised study comparing two prolonged oral antibiotic strategies after initial intravenous ceftriaxone therapy for patients... | |||||||||||||||||||||||||||||||||
Medical condition: Persistent Lyme disease Persistent borreliosis | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005101-51 | Sponsor Protocol Number: RIVM-V/330564/01 | Start Date*: 2013-02-05 | |||||||||||
Sponsor Name:National Institute of Health and the Environment (Dutch acronym: RIVM) | |||||||||||||
Full Title: Tick Test & Prophylaxis Proof | |||||||||||||
Medical condition: Lyme disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000313-37 | Sponsor Protocol Number: T1/2012 | Start Date*: 2012-06-07 | |||||||||||
Sponsor Name:TYKS | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005427-20 | Sponsor Protocol Number: C4601003 | Start Date*: 2022-07-13 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY, AND LOT CONSISTENCY OF A 6 VALENT OspA-BASED LYME DISE... | |||||||||||||
Medical condition: Prevention of Lyme disease caused by Borrelia species in individuals ≥5 years of age by active immunization | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) SE (Ongoing) EE (Prematurely Ended) FI (Ongoing) NL (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000117-39 | Sponsor Protocol Number: A2301 | Start Date*: 2011-06-14 | |||||||||||
Sponsor Name:Ixodes AG. | |||||||||||||
Full Title: A Phase 3 randomized, double-blind, placebo-controlled study of SHB004 (10% topical azithromycin) administered locally twice daily for three consecutive days for the prevention of Borreliosis in su... | |||||||||||||
Medical condition: Lyme borreliosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023384-18 | Sponsor Protocol Number: 730901 | Start Date*: 2011-03-14 | |||||||||||
Sponsor Name:Baxter Innovations GmbH | |||||||||||||
Full Title: Randomized, double-blind, phase I/II clinical study to investigate the safety and immunogenicity of a multivalent recombinant OspA Lyme Borreliosis vaccine (mv rOspA LB Vaccine) in healthy subjects... | |||||||||||||
Medical condition: -) To obtain safety and immunogenicity data of different dose levels of a mv rOspA LB Vaccine with and without adjuvant in seronegative healthy volunteers aged 18 to 70 years. The outcome shall pro... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003379-37 | Sponsor Protocol Number: VLA15-201 | Start Date*: 2019-05-20 | |||||||||||||||||||||
Sponsor Name:Valneva Austria GmbH | |||||||||||||||||||||||
Full Title: IMMUNOGENICITY AND SAFETY STUDY OF VLA15, A MULTIVALENT RECOMBINANT OSPA BASED VACCINE CANDIDATE AGAINST LYME BORRELIOSIS, IN HEALTHY ADULTS AGED 18 TO 65 YEARS - A RANDOMIZED, CONTROLLED, OBSERVER... | |||||||||||||||||||||||
Medical condition: Prevention against Lyme borreliosis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) BE (Completed) AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003166-39 | Sponsor Protocol Number: ChImDLP-2 | Start Date*: 2022-08-08 | |||||||||||
Sponsor Name:UAB Froceth | |||||||||||||
Full Title: A study of the safety of chemoimmunotherapy with autologous Dendritic Cell Preparations in patients with stage III ovarian cancer | |||||||||||||
Medical condition: Stage III of high malignancy Ovarian serous adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: LT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004709-24 | Sponsor Protocol Number: CERL080ANL05 | Start Date*: 2007-03-20 | |||||||||||
Sponsor Name:ErasmusMC | |||||||||||||
Full Title: Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study. | |||||||||||||
Medical condition: Uveitis | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023747-15 | Sponsor Protocol Number: 070411 | Start Date*: 2011-05-03 | |||||||||||
Sponsor Name:University of Oslo | |||||||||||||
Full Title: Tick borne diseases in norwegian general practice. A randomized, controlled trial for treatment of erythema migrans in norwegian general practice. A comparison of phneoxymetylpenicillin, amoxicilli... | |||||||||||||
Medical condition: Erythema migrans (Early Lyme disease) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.